---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-112966"
form_type: "8-K"
ticker: "VASO"
cik: "0000839087"
company_name: "VASO Corp"
filed_at: "2025-11-20T23:59:59+00:00"
generated_at: "2026-05-16T18:17:38.948959+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Vaso sells VasoHealthcare IT to Nano-X for up to $800K; <5% of total revenue

## Summary
- Sale consideration up to $800K: $200K at closing, $600K earnout tied to post-close performance.
- VasoHealthcare IT represented less than 5% of Vaso's total revenue; proceeds to fund other business lines.
- Transaction expected to close within weeks; Vaso engaged Barley Snyder as legal counsel.
- Divestiture follows strategic review; CEO cites sharper focus on core operations as reason.

## SEC filing metadata
- accession: 0001213900-25-112966
- form_type: 8-K
- ticker: VASO
- cik: 0000839087
- company_name: VASO Corp
- filed_at: 2025-11-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/839087/000121390025112966/0001213900-25-112966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/839087/000121390025112966/ea0266535-8k_vaso.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-112966
- JSON: https://secwatch.observer/filing/0001213900-25-112966.json
- Plain text: https://secwatch.observer/filing/0001213900-25-112966.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.